Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gold By Gold | Paris | Basic Materials | Metals & Mining | EUR 14.23M | -35.1x | 0.41 | EUR 5.30 | 17.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Munic | Paris | Technology | Electronic Equipment & Parts | EUR 7.58M | -2.1x | EUR 0.92 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Activium Group | Paris | Technology | Computers, Phones & Household Electronics | EUR 5.25M | EUR 1.60 | -24.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | EUR 442.42K | -9.6x | EUR 0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Eduformaction | Paris | Academic & Educational Services | Professional & Business Education | EUR 10.33M | 2,107.4x | EUR 0.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Glob Bioenergi | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 14.68M | -1.7x | EUR 0.81 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Gentlemen’s Equity | Paris | Financial | Investment Holding Companies | EUR 603.24K | EUR 0.008 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Adomos | Paris | Real Estate | Real Estate Operations | EUR 17.51K | -0x | -0 | EUR 0.0002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Realites | Paris | Real Estate | Real Estate Operations | EUR 10.15M | -0.1x | 0 | EUR 2.05 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | EUR 2.80K | 0x | EUR 0.0003 | 50% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |